Prof. Dr. Min-Ji Charng is a distinguished clinician–scientist and academic based at National Yang-Ming University, Taipei, Taiwan, with recognized expertise in cardiovascular medicine, lipid disorders, and cardiometabolic research. With over 75 peer-reviewed publications and nearly 4,000 citations, his work has achieved significant international impact, reflected in a strong h-index of 25. His research focuses on dyslipidemia, familial hypercholesterolemia, PCSK9 inhibitor therapy, cardiovascular risk stratification, and outcomes research, including sex- and age-related differences in cardiovascular disease. Prof. Charng has published in leading global journals such as Circulation, JAMA Cardiology, and the European Journal of Medical Research, and collaborates extensively with researchers worldwide, as evidenced by a broad co-authorship network. His contributions directly inform clinical guidelines, improve real-world cardiovascular care, and advance precision medicine, yielding measurable benefits for public health and patient outcomes at both national and international levels.